Alpha memo: resveratrol exercise training protocol mismatch

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• Receipt 1 wording says 'slightly blunted' in the memo body but the abstract excerpt shows exercise improved multiple variables; the memo's hedged framing is appropriate but could more explicitly note the specific endpoints (e.g., MAP, VO2max) where blunting was observed.
• Receipt 2 is a letter/re-analysis of the same trial, not an independent dataset — the memo correctly frames it as a re-analysis but could briefly note this is the same ~45-variable dataset rather than independent corroboration.

Reviewer note

This is a clean, bounded alpha memo that does exactly what an Agent-Certified Evidence Map should: it identifies one specific research signal (resveratrol + high-intensity training in healthy aged men, showing modest non-additive effect rather than net-positive ergogenic benefit suggested by animal models), grounds it in two directly relevant receipts (Gliemann 2013 primary trial + 2013 letter re-analysis), and stays proportionate in its claims. The title/anchor (resveratrol + exercise training protocol mismatch) matches the cited receipts perfectly. The abstract is appropriately hedged ('may travel as a net-positive ergogenic aid in animals but show only modest, context-dependent blunting'). The caveats/falsifiers section is specific and material: single trial, n=27, one dose, one duration, one modality, one population, with a concrete pre-registered replication as the decisive falsifier. Source grounding is excellent — both DOIs resolve to the exact papers described, the excerpts confirm the trial design (27 men, ~65y, 250 mg/day trans-resveratrol, 8 weeks, high-intensity training) and the letter's argument (of ~45 variables, exercise improved 12 with no clear additive resveratrol benefit, and the 'adverse effects' framing is embellished). No clinical, policy, or investment claims are made. The memo is honest about its narrow evidentiary base and treats it as a lead signal, not settled consensus. Minor issues are cosmetic only. Recommend accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis